HekeTiss co-founders Nicolò Brembilla and Olivier Preynat-Seauve were featured in an interview by the Office de Promotion des Industries et des Technologies (OPI), presenting the origins and vision of the company.

The discussion highlights the development of TrophiPatch, a regenerative therapy designed to restore vascularization and promote healing in chronic wounds, addressing a major unmet medical need. 

The founders also share insights into the scientific rationale behind the technology, the transition from academic research to a biotech venture, and the challenges associated with bringing advanced therapies to patients. 

Watch the full interview